Introduction {#s001}
============

B[acterial cell division]{.smallcaps} has attracted increasing interest in recent years as a potential target of action for novel antibiotics in the battle against the rise of antimicrobial resistance to current therapies.^[@B1]^ Cell division is undertaken by the coordinated action of a dynamic assembly of proteins termed the divisome.^[@B2]^ A central component of the divisome is FtsZ, the bacterial homologue of tubulin, which drives division at midcell by forming the polymeric dynamic Z-ring that exerts a contractile force on the cytosolic face of the membrane during septal closure.^[@B3]^ Z-ring contraction is accompanied, on the opposite side of the membrane, by the remodeling of the essential peptidoglycan sacculus by penicillin binding proteins (PBPs) and peptidoglycan hydrolases, respectively.^[@B4]^ Division thus requires the coordination of processes on opposite faces of the cytoplasmic membrane. The membrane-associated proteins EzrA and GpsB appear to mediate this coordination in Gram-positive bacteria.^[@B5]^ FtsZ binds directly to the cytoplasmic domain of EzrA,^[@B6],[@B7]^ while bacterial two hybrid studies have revealed the interaction of both EzrA and GpsB with PBPs^[@B5],[@B8],[@B9]^; the interaction of GpsB with PBP1 (PonA), the major peptidoglycan synthase at the cell division septum in *Bacillus subtilis*,^[@B10]^ has also been observed *in vitro* by surface plasmon resonance and fluorescence polarization.^[@B11]^ The deletion of *ezrA* is lethal in *Listeria monocytogenes*^[@B12]^ and *Streptococcus pneumoniae*^[@B13]^ and is accompanied by the mislocalization of FtsZ and PBPs in both *B. subtilis*^[@B5]^ and *Staphylococcus aureus.*^[@B9]^ It is not clear whether *ezrA* is essential in *S. aureus*, as opposing results have been obtained in different laboratories.^[@B8],[@B9]^ Similarly, *gpsB* has been found to be essential in the pathogenic *S. pneumoniae* strain D39, where its depletion causes severe cell division defects,^[@B16]^ but not in other closely-related strains.^[@B13],[@B14],[@B17],[@B18]^ GpsB is important for virulence in *L. monocytogenes*, and here its knockout causes growth defects and increased susceptibility to lysis.^[@B11]^ Severe growth defects and perturbed localization of PBPs occur in *B. subtilis* upon the concurrent deletion of *ezrA* and *gpsB.*^[@B5]^

The importance of GpsB in mediating the coordination of PBP activity with other divisome components is underlined by the interaction network in which GpsB participates. First, GpsB has been reported to interact with EzrA in two hybrid assays, although only unidirectionally,^[@B5]^ potentially providing an indirect link between FtsZ and PBPs, given that numerous *in vitro* and *in vivo* studies have shown that EzrA interacts with FtsZ (*e.g*., 6--9). Second, it has been reported that GpsB is phosphorylated in *B. subtilis* by PrkC,^[@B19]^ a eukaryotic-like membrane-embedded Ser/Thr kinase with an extracellular PASTA domain^[@B20]^ that binds peptidoglycan fragments.^[@B21]^ The relationship between GpsB and PrkC suggests that GpsB could be involved in transducing alterations in cell wall structure on the outside of the cell to the interior. Finally, a major portion of the GpsB sequence is homologous to the lipid binding domain of the DivIVA protein; the lipid binding domain promotes the localization of DivIVA to negatively curved lipid membranes,^[@B22]^ which is pivotal to DivIVA\'s role in promoting the assembly of the divisome at midcell.^[@B23]^ Whether GpsB regulates cell wall synthesis by similarly localizing to curved membranes remains to be clarified.

To help elucidate further the functional role of GpsB, we recently solved crystal structures of its component domains from *L. monocytogenes* (*Lm*GpsB) and *B. subtilis* (*Bs*GpsB).^[@B11]^ GpsB proteins are typically approximately 100 amino acids in length and contain two domains, with the 65--70 amino acid N-terminal domain (N-GpsB) resembling the lipid binding domain of DivIVA, a parallel coiled-coil dimer.^[@B23]^ The 20--25 amino acid C-terminal domain (C-GpsB) forms a parallel triple helical coiled-coil.^[@B11]^ While the N- and C-terminal domains in isolation assemble into dimers and trimers, respectively, the full-length GpsB protein is a hexamer,^[@B11]^ which to date has been recalcitrant to successful crystallization. In this study, we present a study of the arrangement of subunits in *Lm*GpsB using small-angle X-ray scattering (SAXS) and a mutational analysis of candidate oligomer stabilizing residues. To understand the role of GpsB in cell division, we have also analyzed the enzymatic properties of PBP1 in the presence and absence of *Bs*GpsB. In combination, these data are consistent with a model where GpsB serves to localize multiple copies of PBP1, a process that appears to be critical for efficient cell division.

Materials and Methods {#s002}
=====================

Bacterial strains and growth conditions {#s003}
---------------------------------------

All bacterial strains used in this study are listed in [Table 1](#T1){ref-type="table"}. *L. monocytogenes* strains were grown in brain--heart infusion (BHI) broth or on BHI agar plates at 37°C. When necessary, antibiotics and supplements were added to the growth media at concentrations of 50 μg/ml for kanamycin and 1 mM for IPTG. The *Escherichia coli* strain TOP10 was used for all cloning procedures.^[@B24]^

###### 

[Strains and Plasmids Used in This Study]{.smallcaps}

  *Name*                             *Relevant characteristics*                         *Source*^[a](#tf1){ref-type="table-fn"}^*/reference*
  ---------------------------------- -------------------------------------------------- ------------------------------------------------------
  Plasmids                                                                              
  pSH254                             P*~help~-lacO-gpsB lacI neo*                       ^[@B11]^
  pJR133                             P*~help~-lacO-gpsB T88A lacI neo*                  This work
  pJR134                             P*~help~-lacO-gpsB T88D lacI neo*                  This work
  pSH433                             P*~help~-lacO-gpsB F91A lacI neo*                  This work
  pSH434                             P*~help~-lacO-gpsB L94A lacI neo*                  This work
  pSH435                             P*~help~-lacO-gpsB F105A lacI neo*                 This work
  *Listeria monocytogenes strains*                                                      
  EGD-e                              wild-type, serovar 1/2a strain                     ^[@B54]^
  LMJR19                             Δ*gpsB (lmo1888)*                                  ^[@B11]^
  LMS56                              Δ*gpsB attB::*P*~help~-lacO-gpsB lacI neo*         ^[@B11]^
  LMJR161                            Δ*gpsB attB::*P*~help~-lacO-gpsB T88A lacI neo*    pJR133 → LMJR19
  LMJR162                            Δ*gpsB attB::*P*~help~-lacO-gpsB T88D lacI neo*    pJR134 → LMJR19
  LMS185                             Δ*gpsB attB::*P*~help~-lacO-gpsB F91A lacI neo*    pSH433 → LMJR19
  LMS186                             Δ*gpsB attB::*P*~help~-lacO-gpsB L94A lacI neo*    pSH434 → LMJR19
  LMS187                             Δ*gpsB attB::*P*~help~-lacO-gpsB F105A lacI neo*   pSH435 → LMJR19

The arrow (→) stands for a transformation event.

Construction of plasmids and strains {#s004}
------------------------------------

The T88A, T88D, F91A, L94A, and F105A amino acid exchanges were introduced into *L. monocytogenes gpsB*, cloned previously into pSH254, by Quikchange mutagenesis^[@B25]^ using the primer pairs JR290/JR291, JR291/JR293, JR311/JR312, JR313/JR314, and JR315/JR316, respectively ([Table 2](#T2){ref-type="table"}). The presence of the desired mutations was verified by DNA sequencing. The resulting plasmids are listed in [Table 1](#T1){ref-type="table"} and were introduced into *L. monocytogenes* EGD-e by electroporation.^[@B26]^ Kanamycin-resistant clones were selected, and plasmid insertion at the *attB* site of the tRNA^Arg^ locus was verified by PCR.

###### 

[Oligonucleotides Used in This Study]{.smallcaps}

  *Name*   *Sequence (5′→3′)*
  -------- ------------------------------------------------------------
  JR290    GTTGGTTGCTCCAGCAGGTTGTG
  JR291    CTGCTGGAGCAACCAACTTTGATATTC
  JR292    GTTGGTGTCTCCAGCAGGTTGTG
  JR293    CTGCTGGAGACACCAACTTTGATATTC
  JR311    GGAACAACCAACGCTGATATTCTAAAG
  JR312    CTTTAGAATATCAGCGTTGGTTGTTCC
  JR313    GATATTGCAAAGCGTCTTTCTAATTTAG
  JR314    CTAAATTAGAAAGACGCTTTGCAATATC
  JR315    GAAAAACATGTTGCTGGAAATAAGCTG
  JR316    CAGCTTATTTCCAGCAACATGTTTTTC
  RC91f    CACAACCTGCTGGAACAACCAACGCTGATATTCTAAAGCGTCTTTC
  RC91r    GAAAGACGCTTTAGAATATCAGCGTTGGTTGTTCCAGCAGGTTGTG
  RC105f   CGTCTTTCTAATTTAGAAAAACATGTTGCTGGAAATAAGCTGGACGATAACG
  RC105r   CGTTATCGTCCAGCTTATTTCCAGCAACATGTTTTTCTAAATTAGAAAGACG
  RC75Ef   CAGCCTGTGCAATCTAACGAAACAAACTTTGATATTTTAAAACG
  RC75Er   CGTTTTAAAATATCAAAGTTTGTTTCGTTAGATTGCACAGGCTG
  RC75Df   CAGCCTGTGCAATCTAACGATACAAACTTTGATATTTTAAAACGGCTGTCTAACTTAG
  RC75Dr   CTAAGTTAGACAGCCGTTTTAAAATATCAAAGTTTGTATCGTTAGATTGCACAGGCTG
  RC87f    GCACAACCCATGGGAACAACCAACTTTGATATTCTAAAGCG
  RC113r   CATAAGCTCGAGTTTCTCGCTCGTGGGGTTTAC

To generate the plasmid for expressing C-*Lm*GpsB, the open reading frame encoding *L. monocytogenes* GpsB residues 87--113 was PCR amplified from genomic DNA from strain EGD-e with primers RC87f and RC113f, which contain flanking *Nco*I and *Xho*I restriction sites, and cloned between the *Nco*I and *Xho*I sites of pMAT11, a modified form of pHAT4.^[@B27]^ The plasmids for expressing the full-length *Lm*GpsB~F91A~, *Lm*GpsB~F105A~ mutants and the double mutant *Lm*GpsB~F91AF105A~ were prepared by Quikchange mutagenesis using primers RC91f, RC91r, RC105f, and RC105r; for the double mutant, two rounds of mutagenesis were used---the first round with primer pairs RC91f and RC91r and the second round with primer pairs RC105f and RC105r ([Table 2](#T2){ref-type="table"}).

Similarly, the full-length *Bs*GpsB~T75E~ and *Bs*GpsB~T75D~ mutants were prepared by Quikchange mutagenesis with primers RC75Ef and RC75Er, and RC75Df and RC75Dr, respectively; the plasmid for expressing full-length wild-type *Bs*GpsB was used as a template for the Quikchange reaction to generate the T75D mutation. By contrast, for the T75E Quikchange reaction, the plasmid for expressing *Bs*GpsB~T75D~ was used as a template. The resultant plasmids were sequenced to verify the successful introduction of the desired mutations and were subsequently used for the overproduction of the full-length GpsB variants by the same procedures as wild-type GpsB proteins.^[@B11]^

Isolation of cellular proteins and Western blotting {#s005}
---------------------------------------------------

Cells were harvested by brief centrifugation in a table-top microfuge and washed with ZAP buffer (10 mM Tris-HCl pH 7.5, 200 mM NaCl). Cells were resuspended in 1 ml ZAP buffer containing 1 mM PMSF and disrupted by sonication. The cell debris was removed by centrifugation, and the supernatant was used as the soluble protein extract. Protein samples were separated by SDS polyacrylamide gel electrophoresis and then transferred onto positively charged polyvinylidene fluoride (PVDF) membranes using a semidry transfer unit. GpsB and DivIVA were detected using polyclonal rabbit antisera raised against *L. monocytogenes* GpsB^[@B11]^ and *B. subtilis* DivIVA,^[@B28]^ respectively, with anti-rabbit immunoglobulin G conjugated to horseradish peroxidase as the secondary antibody. The ECL chemiluminescence detection system (Thermo Scientific) was then used for detection of the peroxidase conjugates on the PVDF membranes in a chemiluminescence imager (Vilber Lourmat).

Protein purification {#s006}
--------------------

PBP1 and GpsB proteins were purified as described previously.^[@B11]^ C-*Lm*GpsB proteins were expressed as fusion proteins with N-terminal His~6~- and MBP-tags; the protocols for expression and purification of the fusion protein by Ni-NTA chromatography were as described previously for C-*Bs*GpsB.^[@B11]^ Following Ni-NTA chromatography, the fusion protein was cleaved with TEV protease (ratio of fusion protein:TEV 50:1 by mass) overnight at 4°C while simultaneously dialyzing into a buffer of 50 mM Tris-HCl pH 8.0, 300 mM NaCl using a 2 kDa molecular weight cutoff dialysis membrane. The dialysate was passed back over a 5 ml Ni-NTA cartridge (Qiagen) to separate TEV protease, C-*Lm*GpsB released by cleavage from the fusion protein and residual uncleaved His~6~-MBP-C-*Lm*GpsB. The flow through from the Ni-NTA column was concentrated in a centrifugal concentrator to 1 ml and loaded onto a Superdex75 XK16/60 column (GE Healthcare) equilibrated in a buffer of 10 mM Tris-HCl pH 8.0, 250 mM NaCl. Elution fractions containing C-*Lm*GpsB were pooled, concentrated to *c*. 5 mg/ml in a centrifugal concentrator, and then dialyzed further into 20 mM sodium phosphate pH 7.8, 250 mM NaCl before finally flash freezing the protein in liquid nitrogen and storing at −80°C.

Size exclusion chromatography {#s007}
-----------------------------

The full-length wild-type *Lm*GpsB and *Lm*GpsB~F91A~, *Lm*GpsB~F105A~ and *Lm*GpsB~F91AF105A~ proteins were analyzed on a Superdex200 Increase 10/300 GL column (GE Healthcare) equilibrated in 10 mM Tris-HCl pH 8.0, 250 mM NaCl, at a flow rate of 0.5 ml/min. Protein samples at 3 mg/ml concentration were injected onto the column through a 100 μl sample loop. Wild-type *Bs*GpsB and the *Bs*GpsB~T75D~ and *Bs*GpsB~T75E~ mutants were analyzed under the same conditions, except the protein concentration was 1 mg/ml.

Size exclusion chromatography-MALS {#s008}
----------------------------------

GpsB samples (500 μl) at concentrations of 8 mg/ml or 0.5 mg/ml were loaded onto a Superdex200 Increase 10/300 GL column (GE Healthcare) equipped with a Jasco UV-2077 detector, Wyatt DAWN Heleos II EOS 18-angle laser photometer (with the 13th detector replaced with the QELS in-line dynamic light scattering detector) coupled to a Wyatt Optilab rEX refractive index detector. The flow rate was 0.75 ml/min. Molecular mass and concentrations of the peaks eluting from the column in a running buffer of 10 mM Tris-HCl pH 8.0, 250 mM NaCl were analyzed using Astra 6.2 ([www.wyatt.com/products/software/astra.html](www.wyatt.com/products/software/astra.html)).

Circular dichroism {#s009}
------------------

CD thermal melts were measured in a 1-mm path length quartz cuvette in a 20 mM sodium phosphate pH 7.8, 200 mM NaCl buffer for wild-type *Lm*GpsB, N-*Lm*GpsB, and C-*Lm*GpsB and in 20 mM sodium phosphate pH 7.8, 250 mM NaCl for wild-type *Bs*GpsB, *Bs*GpsB~T75D~, and *Bs*GpsB~T75E~. The temperature was increased at a rate of 1°C/min, and ellipticity was monitored at a wavelength of 222 nm with a response time of 8 seconds and bandwidth of 2 nm. The reversibility of the melts was verified by recording spectra in the wavelength range 200--240 nm (scan speed 20 nm/min, response 2 seconds) before and after the melt, to check that the spectra were superimposable. Protein concentrations were 23 μM for wild-type *Lm*GpsB, N-*Lm*GpsB, and C-*Lm*GpsB, 29 μM for *Lm*GpsB~F91AF105~, and 5 μM for wild-type *Bs*GpsB, *Bs*GpsB~T75D~, and *Bs*GpsB~T75E~.

The CD spectra of wild-type and C-*Lm*GpsB~F105A~ proteins were recorded at protein concentrations of 23 and 33 μM, respectively, in a buffer of 20 mM sodium phosphate pH 7.8 at 20°C. The scan speed was 10 nm/min, and the response time was 4 seconds. Protein concentrations were determined based on calculated extinction coefficients at 280 nm^[@B29]^ for *Lm*GpsB, N-*Lm*GpsB, and *Bs*GpsB proteins; for the C-LmGpsB proteins, which lack tryptophan and tyrosine residues, amino acid analysis was used instead to quantify concentration. Secondary structure composition was evaluated from the spectra using the program CDSSTR^[@B30]^ within the DICHROWEB^[@B31]^ server.

SAXS data collection and processing {#s010}
-----------------------------------

The *Lm*GpsB and N-*Lm*GpsB proteins were analyzed in a buffer of 10 mM Tris-HCl pH 8.0, 150 mM NaCl at a protein concentration of 40 mg/ml. SAXS intensity data, *I*(*q*) versus *q*, (*q* = 4π*sin*2θ/λ, where 2θ is the scattering angle) were collected using batch-mode SAXS on beamline P12 at PETRAIII (DESY; Hamburg), or batch mode and inline size exclusion chromatography (SEC)-SAXS on beamline B21, Diamond Light Source. Batch-mode SAXS was completed using 30 μl of *Lm*GpsB or N-*Lm*GpsB in a dilution series, which was loaded onto the beamline using the EMBL automated sample changer.^[@B32]^ SAXS data were collected at PETRAIII with 0.5 second exposures onto a 2 M Pilatus detector (Dectris) at a distance of 3.0 m and an X-ray wavelength of 1.24 Å; these data were reduced and subtracted using in-house software.^[@B33]^

For SEC-SAXS data collection at Diamond, 50 μl of *Lm*GpsB was loaded onto a Superdex 200 Increase 3.2/300 column and the eluent flowed through the SAXS beam at a flow rate of 0.1 ml/min; the buffer used as the blank in these measurements was the eluent after one SEC column volume. SAXS data were constantly collected at 1 second intervals using a 2 M Pilatus detector (Dectris) at a distance of 3.9 m and an X-ray wavelength of 1 Å. Subtraction of the SEC-SAXS data was completed for each frame across the elution peak, and the radius of gyration (R~g~) and the integral of ratio to background were plotted. The data were scaled, merged, and averaged for each frame with a consistently similar R~g~. All further processing and analysis of data were carried out using ScÅtter ([www.bioisis.net/scatter](www.bioisis.net/scatter)).

Pair distance distribution functions were calculated with GNOM,^[@B34]^ with D~max~ values for *Lm*GpsB and N-*Lm*GpsB of 185 and 76 Å; the D~max~ values were estimated initially using DATGNOM and the atomic coordinates of N-*Lm*GpsB,^[@B11]^ from which the pair distance distribution function was calculated with ScÅtter; all waters and heteroatoms were removed before the calculation.

SAXS model generation {#s011}
---------------------

Dummy atom models were constructed in DAMMIN in slow mode using scattering data up to a maximum *q* value of 8/R~g~ (0.15Å^−1^ for *Lm*GpsB, 0.36Å^−1^ for *N*-LmGpsB). For N-*Lm*GpsB, the chi-squared values calculated by DAMMIN, corresponding to the agreement between experimental scattering curves and scattering curves calculated from the dummy atom models, ranged between 1.60 and 1.64. For *Lm*GpsB, the chi-squared values from individual DAMMIN run were in the range 1.11--1.14. For N- *Lm*GpsB, the average normalized structural discrepancy (NSD) between models from 10 independent DAMMIN runs, after averaging them together in the DAMAVER suite,^[@B35]^ was 0.539 ± 0.09. For *Lm*GpsB, the models from 15 DAMMIN runs were superimposed and averaged in the DAMAVER suite and the averaged model was then input into DAMSTART to generate a starting model for a further 15 DAMMIN runs. The final models were then again averaged together using the DAMAVER suite; the NSD between models was 0.552 ± 0.09.

Dummy atom models were visualized in CHIMERA^[@B36]^ by representing the atoms as beads, with the bead scale adjusted to a value equivalent to the dummy atom radius divided by 0.7. The surface mesh representation of dummy atom models was generated by using the CHIMERA "molmap" command to convert the model to the equivalent electron density map at 25 Å resolution---the contouring of this map was then adjusted to enclose the surface of the dummy atoms. The crystal structures of the N- and C-terminal domains of GpsB^[@B11]^ PDBids 4ug1 and 5an5, respectively, were also represented as 25 Å resolution electron density maps using the "molmap" command in CHIMERA. For the *Lm*GpsB sample, the molecular weight of the scattering particles was calculated from the volume of correlation^[@B37]^ using ScÅtter.

Production of lipid II-*meso*-diaminopimelic acid {#s012}
-------------------------------------------------

Lipid II-*meso*-diaminopimelic acid (Lipid II-*m*-DAP) was synthesized using UDP-Mur*N*Ac-pentapeptide isolated from *Bacillus cereus*, essentially as described previously^[@B38],[@B39]^ with the following modifications. Purification was performed over a DEAE-cellulose column using a linear gradient of chloroform/methanol/water (2:3:1 v/v/v) to chloroform/methanol/1 M ammonium bicarbonate (2:3:1 v/v/v). The fractions containing Lipid II-*m*-DAP were collected and dried under vacuum. The resulting lipid II-*m*-DAP was then dissolved in 1:1 chloroform:methanol and stored at −20°C until use.

Production of \[^[@B14]^C\]-amidated Lipid II-*m*-DAP {#s013}
-----------------------------------------------------

The ability of MurG to exchange the Glc*N*Ac group between UDP-Glc*N*Ac and Lipid II was used to radioactively label Lipid II. Since the *E. coli* MurG used here displayed much lower affinity for amidated Lipid II-*m*-DAP than the nonamidated form, we first synthesized \[^[@B14]^C\]-Lipid II-*m*-DAP and then amidated this using AsnB from *B. subtilis*. First, 1.22 μmol of purified lipid II-*m*-DAP was incubated with 12.5 μCi of UDP-*N-*acetyl-D-\[1-^[@B14]^C\]glucosamine (specific activity 55 mCi/mmol) (Hartmann Analytic GmbH). The labeling reaction was performed in 1 ml of 100 mM Tris-HCl, pH 8.0, 1 mM MgCl~2~, and 2% (w/v) Triton X-100. The reaction was started by the addition of 1 μL purified recombinant *E. coli* MurG, which is able to exchange the *N*-acetyl-D-glucosamine of lipid II with that of UDP-*N*-acetyl-D-\[1-^[@B14]^C\]glucosamine. After incubation at room temperature for 2.5 hours, the reaction was complete as determined by liquid scintillation counting.

To amidate the carboxylic acid group of the *m*-DAP, lipid II-DAP was incubated with *B. subtilis* AsnB in the presence of ATP and glutamine (to be published elsewhere), followed by extraction using butanol/pyridine acetate, pH 4.2, and another purification step over a DEAE cellulose column using a gradient of chloroform/methanol/water (2:3:1 v/v/v) to chloroform/methanol/0.5 M ammonium bicarbonate (2:3:1 v/v/v).

*In vitro* peptidoglycan synthesis assays {#s014}
-----------------------------------------

The continuous fluorescence glycosyltransferase (GTase) assay using dansyl-labeled lipid II as the substrate was performed essentially as described previously,^[@B40]^ with only minor modifications to buffer conditions and temperature. We also used an endpoint assay to measure the GTase and transpeptidase (TPase) activity under the same experimental conditions. The activity of *Bs*PBP1 (0.4 μM) was measured at 37°C in the absence and presence of 10 μM *Bs*GpsB proteins in 50 mM HEPES.NaOH pH 7.5, 20 mM NaCl, 10 mM CaCl~2~, and 5% (v/v) glycerol. The endpoint assay used \[^[@B14]^C\]-labeled native amidated lipid II-*m*-DAP substrate followed by the quantification of both GTase and TPase products by high-pressure liquid chromatography (HPLC) as described previously.^[@B41]^

Results {#s015}
=======

Low resolution model of subunit arrangement in solution by SAXS {#s016}
---------------------------------------------------------------

In the absence of diffracting crystals of full-length *Lm*GpsB, SAXS was used to determine its low resolution structure since the correct assembly of subunits in *Lm*GpsB is highly pertinent to the protein\'s function. To validate this approach, we first analyzed N-*Lm*GpsB for which the crystal structure has already been solved.^[@B11]^ The measured scattering profile for N-*Lm*GpsB matched favorably with the theoretical profile calculated from the corresponding atomic coordinates ([Fig. 1A](#f1){ref-type="fig"}). From a Guinier analysis of the scattering profile, an R~g~ of 21.4 Å was obtained, while the pair distribution function calculated by inverse Fourier transformation with GNOM^[@B34]^ gave an R~g~ of 22.2 Å. These values compare extremely favorably with an R~g~ value of 21.4 Å that was calculated from the atomic coordinates with CRYSOL.^[@B42]^ Finally, *ab initio* dummy atom molecular models built from the scattering data with DAMMIN^[@B43]^ reproduced well the shape and dimensions of the dimeric N-*Lm*GpsB ([Fig. 1B](#f1){ref-type="fig"}).

![SAXS analysis of N-*Lm*GpsB. **(A)** SAXS scattering curves (*top*), Guinier plots (*middle*), and pair distribution functions (*bottom*) for N-*Lm*GpsB. The experimentally observed scattering curve is shown as a *black solid line* and the scattering curve, calculated from the coordinates with CRYSOL (42), as a *red dashed line*. The chi-squared value for the agreement between the two curves in the *q* range 0--0.25 Å^−1^ is 1.8. For the pair distribution function of the N-*Lm*GpsB, the *red dashed plot* represents the profile calculated from the coordinates with the ScÅtter software. **(B)** SAXS-derived *ab-initio* dummy atom models of N-*Lm*GpsB calculated with DAMMIN from small-angle X-ray scattering profiles. Representative models are shown from three independent DAMMIN calculations. The dummy atom model is shown in surface representation rendered in mesh. The coordinates of the N-*Lm*GpsB dimer (*red*) have been manually docked inside the mesh, represented either in ribbon form or as the equivalent electron density maps would appear at 25 Å. SAXS, small-angle X-ray scattering.](fig-1){#f1}

Analysis of *Lm*GpsB yielded the best quality data on SAXS beamlines with an in-line SEC facility. The monodispersity of *Lm*GpsB samples after in-line SEC was indicated by the linearity of Guinier plots at *q* values less than 1.3/R~g~ ([Fig. 2A](#f2){ref-type="fig"}). The molecular mass of the scattering particles after in-line SEC, calculated from the volume of correlation,^[@B37]^ was 75,900 Da, which is within 5% of the actual mass of the expressed *Lm*GpsB protein when assembled as a hexamer.

![SAXS analysis of *Lm*GpsB. **(A)** SAXS scattering curves (*top*), Guinier plots (*middle*), and pair distribution functions (*bottom*) for *Lm*GpsB. **(B)** Analysis of the flexibility of the N-*Lm*GpsB (*top*) and the *Lm*GpsB protein (*bottom*) by Porod--Debye plots. The plateau in the plot for N-*Lm*GpsB is consistent with a compact folded protein.](fig-2){#f2}

A Porod--Debye analysis of the comparative flexibility of *Lm*GpsB and N-*Lm*GpsB suggested that the full-length protein is more flexible than the isolated N-terminal domain. The Porod--Debye plot for N-*Lm*GpsB rose to a plateau ([Fig. 2B](#f2){ref-type="fig"}), which is characteristic of a folded compact protein.^[@B44]^ By contrast, the Porod--Debye plot for *Lm*GpsB had a less pronounced plateau and instead conformed to a hyperbole. The relatively shallow gradient of the asymptote, however, indicated that *Lm*GpsB is markedly less flexible than a completely unfolded protein. Given the successful crystal structure determinations of both N- and C-terminal domains of GpsB, the flexibility within *Lm*GpsB is most likely attributable to the linker region between the domains.

The pair distribution function of *Lm*GpsB had, like N-*Lm*GpsB, the characteristics of an elongated molecule,^[@B45]^ with a steep initial increase in P(r) to a maxima followed by a more gradual decrease to zero at D~max~. From the Guinier plot and pair distribution functions, R~g~ values of 51.2 and 53.1 Å were obtained for *Lm*GpsB. *Ab initio* dummy atom molecular models were calculated in DAMMIN without symmetry constraints, however, no obvious symmetric relationships were apparent from the resultant models. A notable feature of the models is two distinct lobes of different sizes connected by a narrower central region ([Fig. 3](#f3){ref-type="fig"}).

![SAXS molecular envelopes for *Lm*GpsB. **(A)** The average surface of 15 independently generated *ab initio Lm*GpsB dummy atom models is represented as a mesh. Three of these models are represented in **(B)** to illustrate the level of variation. The coordinates of N-*Lm*GpsB dimers (*red and cyan*) and the C-*Lm*GpsB trimers (*blue*) were docked manually and are shown in ribbon form (*right column*) or as equivalent electron density maps would appear at 25 Å resolution (*left, middle columns*). The coordinates shown correspond to residues 5--67 (N-terminal domain) and 89--106 (C-terminal domain) of *Lm*GpsB*; Lm*GpsB has a total of 113 residues. The models do not include the linker between domains. In the arrangements shown in **(B)**, with the simplest of the possible connectivities between domains, the chain termini are separated by distances of up to 55 Å. By comparison, a fully extended 21 polypeptide residue chain would be ∼80 Å in length, and therefore, the models are compatible with the domains being connected by an appropriate length linker in a semicompact conformation.](fig-3){#f3}

The most logical arrangement of the individual domains in the GpsB hexamer resembles a tripod with the three dimeric N-GpsB domains aligned as in the legs in a tripod with the two C-GpsB trimeric domains encompassing its base ([Fig. 4A](#f4){ref-type="fig"}). Such an arrangement is logical on the basis that it presents a relatively straight path and near equivalent distance between connected C- and N-terminal domains of GpsB. Manually positioning the atomic coordinates of the N- and C-terminal domains of GpsB into the *ab initio* dummy atom model supports such a tripod arrangement ([Fig. 3](#f3){ref-type="fig"}); the three N-GpsB dimers encompass the larger of the two lobes, and the two C-GpsB trimers correspond to the smaller one.

![Interaction between GpsB domains. **(A)** *A priori* hypothetical arrangement of the N- and C-terminal domains of GpsB, as described in the text. N-*Lm*GpsB dimers are colored *cyan and red*; C-*Lm*GpsB trimers *blue*. The putative path taken by interdomain linkers is represented as a *black dotted line*. Note the N-*Lm*GpsB dimer colored *cyan* is covalently linked to two separate C-*Lm*GpsB trimers and thus forms a bridge between two trimers that would stabilize association into a hexamer. **(B)** The interface between adjacent (*red and green*) C-*Bs*GpsB molecules as observed in its crystal lattice, with the key hydrophobic interfacial residues F78, L81, and F92 drawn as *sticks* and colored *black*. The *lower panel* also shows V91, a residue in the hydrophobic core of the C-*Bs*GpsB trimer, which packs against the interfacial residue F92. In the *lower panel*, the numbering of the *Listeria monocytogenes* GpsB equivalents of *Bs*GpsB F78, L81, V91, and F92 is shown in *italics* in parentheses.](fig-4){#f4}

The importance of hexamer formation for GpsB activity *in vivo* {#s017}
---------------------------------------------------------------

The tripod model positions the two C-*Lm*GpsB trimers in close proximity. The lattice interactions in the crystal structure of C-*Bs*GpsB (encompassing residues 76--98 of *Bs*GpsB) are thus of interest in considering how the subunits assemble to form the GpsB hexamer. Two highly conserved phenylalanines (F78, F92) stand out for being highly solvent exposed on the surface of the C-*Bs*GpsB trimer; within the crystal lattice both F78 and F92 are buried at the interface between adjacent trimers ([Fig. 4B](#f4){ref-type="fig"}). To probe whether burial of these residues drives the assembly of subunits within the full-length hexameric GpsB, the equivalent residues in *Lm*GpsB, F91, and F105 were mutated to alanine, both singly and in combination. The oligomeric state of the wild-type and the mutant proteins was analyzed by SEC. Mutation of F105 to alanine both alone and in combination with the F91A mutation substantially increased the retention volume of *Lm*GpsB mutants on SEC analysis relative to the wild-type *Lm*GpsB ([Fig. 5A](#f5){ref-type="fig"}). Subsequent SEC-MALS analysis of the *Lm*GpsB~F91AF105A~ double mutant confirmed this is due to a change in the oligomeric state; the double mutant formed a trimer at high protein concentrations and a dimer at lower concentrations ([Fig. 5B](#f5){ref-type="fig"}). Mutation of F91A alone had an intermediate effect on assembly, with SEC analysis revealing two species; the predominant peak has a similar retention volume as the hexameric wild-type protein, while the other peak has a retention volume more similar to the F91AF105A double mutant ([Fig. 5B](#f5){ref-type="fig"}).

![SEC and SEC-MALS analysis of GpsB proteins. **(A)** SEC analysis of wild-type *Lm*GpsB (*solid black line*), *Lm*GpsB~F91A~ (*solid green line*), *Lm*GpsB~F105A~ (*solid red line*), and *Lm*GpsB~F91AF105A~ (*dashed black line*) proteins at 3 mg/ml concentration. **(B)** SEC-MALS analysis of wild-type *Lm*GpsB (*solid black line*) and *Lm*GpsB~F91AF105A~ (*dashed black line*) proteins. The chromatograms represent analysis at two injected protein concentrations of 8 mg/ml (*top*) and 0.5 mg/ml (*bottom*). The deconvoluted molecular masses of the eluting species (*red dashed lines*) are plotted on the *right hand* axis. The average of 76 kDa and 38.9 kDa across the major peak for wild-type *Lm*GpsB and *Lm*GpsB~F91AF105A~ at 8 mg/ml is consistent with the theoretical mass of a hexamer (79 kDa) and trimer (38.6 kDa). At lower protein concentrations, the average mass of *Lm*GpsB~F91AF105A~ is 26 kDa, consistent with the theoretical mass of a dimer (25.8 kDa), whereas the wild-type *Lm*GpsB remains hexameric. **(C)** SEC of wild-type *Bs*GpsB (*solid black line*), *Bs*GpsB~T75E~ (*dashed blue line*), and *Bs*GpsB~T75D~ (*solid red line*) mutants, all at 1 mg/ml. These phosphomimetic mutations do not introduce any significant change to the oligomeric state of *Bs*GpsB. SEC, size exclusion chromatography.](fig-5){#f5}

The structural importance of F91 and F105 is further supported by thermal stability analysis using circular dichroism spectroscopy. Wild-type *Lm*GpsB has a T~m~ (the temperature of the midpoint of thermal unfolding) of 50°C, whereas the *Lm*GpsB~F91AF105A~ double mutant has a T~m~ of 45°C ([Fig. 6A](#f6){ref-type="fig"}). At the protein concentrations used for the CD analysis, the *Lm*GpsB~F91AF105A~ double mutant was observed to be a dimer on SEC-MALS analysis ([Fig. 6B](#f6){ref-type="fig"}), which may explain why *Lm*GpsB~F91AF105A~ has a similar T~m~ as the dimeric, isolated N-*Lm*GpsB domain ([Fig. 6A](#f6){ref-type="fig"}).

![Circular dichroism spectra. **(A)** Thermal denaturation of *Lm*GpsB (*black line*), N-*Lm*GpsB (*orange line*), C-*Lm*GpsB (*cyan line*), and *Lm*GpsB~F91AF105A~ (*red line*), monitored by circular dichroism; the *dashed line* represents the summation of the individual thermal melts measured for N-*Lm*GpsB and C-*Lm*GpsB. Unfolding of the secondary structure is observed by monitoring ellipticity at 222 nm. The F91AF105A mutation reduces the stability of *Lm*GpsB. **(B)** Circular Dichroism spectra of wild-type C-*Lm*GpsB (*top*) and C-*Lm*GpsB~F105A~ (*bottom panel*). The *dashed* spectrum represents the reconstructed spectra after fitting the secondary structural content with the program CDSStr (30). **(C)** Thermal denaturation of wt *Bs*GpsB (*black line*), *Bs*GpsB~T75D~ (*red line*), and *Bs*GpsB~T75E~ (*cyan line*) monitored by circular dichroism ellipticity at 222 nm. The midpoint of the unfolding transition is similar for the three proteins (*c*. 62°C).](fig-6){#f6}

To further investigate the structural role of F105, the alanine substitution was made within the context of the isolated C-terminal domain. The isolated C-terminal domain forms trimers, rather than hexamers, in solution,^[@B11]^ and F105 is exposed on the surface of this trimer, rather than in the hydrophobic core. F105 is unlikely to have an important structural role within the isolated C-terminal domain, but will stabilize the hexameric full-length protein. However, the C-*Lm*GpsB~F105A~ fold was markedly destabilized as the alpha helical content was reduced from 70% in the wild-type C-*Lm*GpsB protein to 10% in the F105A mutant. This effect can perhaps be reconciled on closer analysis of the structure of C-*Bs*GpsB; F92 (equivalent to F105 in *L. monocytogenes* GpsB) is in close proximity to the hydrophobic core residue V91, and while one face of the F92 aromatic ring is surface exposed, the other face packs against V91 ([Fig. 4B](#f4){ref-type="fig"}). The structural importance of F105 may therefore have two components; first, F105 stabilizes indirectly the folding of the isolated C-terminal domain because of its interaction with Val104, and second, F105 is likely to stabilize further interactions between C-GpsB trimers within the GpsB hexamer, by packing against Phe91 and Leu94 in another protomer in the hexamer ([Fig. 4B](#f4){ref-type="fig"}). The dimers and trimers observed with the *Lm*GpsB~F91AF105A~ double mutant likely arose from misfolding of at least the C-terminal domain, given the loss of secondary structure associated with the F105A mutation ([Fig. 6A](#f6){ref-type="fig"}).

To validate the effect of mutations in the interface between C-GpsB trimers, we used a complementation assay to measure the effect of *gpsB* mutations on GpsB activity in *L. monocytogenes*. Briefly, the *L. monocytogenes* Δ*gpsB* mutant grew equally well as the wild-type strain at 30°C and was still viable at 37°C; however, the *L. monocytogenes* Δ*gpsB* mutant was not viable at 42°C, neither were *gpsB* mutants affected in self-interactions or interactions with the *L. monocytogenes* orthologue of *B. subtilis* PBP1, PBP A1 (for simplicity referred to herein as PBP1).^[@B11]^ Mutations that individually exchanged the pair of phenylalanines (F91, F105, the equivalent B. subtilis residues are highlighted on the structure in [Figure 4](#f4){ref-type="fig"}) and the adjacent L94 into alanines were introduced to *L. monocytogenes gpsB*, and the resulting alleles were tested in the complementation assay. As shown in [Fig. 7A](#f7){ref-type="fig"}, the wild-type *L. monocytogenes* strain EGD-e proliferated readily at 42°C, whereas the Δ*gpsB* mutant (strain LMJR19) was unable to grow at all at this temperature. Reintroduction of wild-type *gpsB* into the Δ*gpsB* mutant (strain LMS56) repaired this defect, demonstrating successful complementation. The point mutations introduced fell into two classes: strain LMS185, expressing *gpsB~F91A~* was able to grow at 42°C, although with increased autolysis in the stationary phase as observed by phase contrast microscopy (not shown) and by growth curve analysis ([Fig. 7A](#f7){ref-type="fig"}), suggesting that the *in vivo* activity of *Lm*GpsB~F91A~ was partially impaired. By contrast, mutations L94A and F105A completely prevented growth of strains LMS186 and LMS187, respectively ([Fig. 7A](#f7){ref-type="fig"}), indicating that these amino acid exchanges generated biologically inactive GpsB proteins. Western blotting showed that all the GpsB mutant proteins were expressed both during growth at 37°C, where all strains are viable ([Fig. 7C](#f7){ref-type="fig"}), and also 2 hours after a temperature shift to 42°C ([Fig. 7D](#f7){ref-type="fig"}). The loss of growth at 42°C is therefore more likely to result from a loss of a functional property of GpsB rather than a loss of protein production or its degradation.

![Effect of mutations in the GpsB C-terminus on growth of *L. monocytogenes* at 42°C. **(A)** *L. monocytogenes* strains EGD-e (wt), LMJR19 (Δ*gpsB*), LMS56 (Δ*gpsB+gpsB*), LMS185 (Δ*gpsB+gpsBF91A*), LMS186 (Δ*gpsB+gpsBL94A*), and LMS187 (Δ*gpsB+gpsBF105A*) were grown in BHI broth containing 1 mM IPTG at 42°C, and growth was recorded in hourly intervals. **(B)** Growth of *L. monocytogenes* strains EGD-e (wt), LMJR19 (Δ*gpsB*), LMS56 (Δ*gpsB+gpsB*), LMJR161 (Δ*gpsB+gpsBT88A*), and LMJR162 (Δ*gpsB+gpsBT88D*) was measured as described in **(A)**. All average values and standard deviations were calculated from experiments performed in triplicate. **(C)** Western blots showing expression of *Lm*GpsB proteins in the same set of strains as in **(A, B)** during growth at 37°C (*top panel*). Cells were harvested for protein isolation at an optical density of 1.0 (λ = 600 nm). A parallel Western blot shows DivIVA expression for control (*bottom panel*). **(D)** Stability of *Lm*GpsB proteins after temperature upshift to 42°C. Western blot showing amounts of *Lm*GpsB proteins in cells that were grown at 37°C to an optical density of 1.0 and then shifted to 42°C for 2 further hours before protein isolation (*top panel*). Again, a parallel Western blot shows DivIVA protein levels for control (*bottom panel*).](fig-7){#f7}

Role of the phosphorylation of GpsB {#s018}
-----------------------------------

It has been reported recently that GpsB was phosphorylated in *B. subtilis* cells at T75 (T88 in *Lm*GpsB) by the kinase PrkC.^[@B19]^ The phosphomimetic mutations T75D and T75E appeared to have the same salt-sensitive phenotype as a *gpsB* deletion.^[@B19]^ Likewise, we found that the introduction of the analogous T88D exchange into *Lm*GpsB almost completely inactivated the protein. However, the phosphoablative T88A mutation was without effect on complementation activity of *Lm*GpsB ([Fig. 7B, D](#f7){ref-type="fig"}). T75 in *Bs*GpsB and T88 in *Lm*GpsB are located in the linker between the two domains. To investigate whether the T75E and T75D mutations had any impact on the hexamerization of *Bs*GpsB, full-length, wild-type, T75E and T75D mutant *Bs*GpsB proteins (*Bs*GpsB~T75E~ and *Bs*GpsB~T75D~) were analyzed by SEC in conditions under which wild-type *Bs*GspB was shown by SEC-MALS to form a stable hexamer.^[@B11]^ The T75E and the T75D mutations did not have a major effect on the size exclusion chromatograms of *Bs*GpsB; the major species in wild-type and both mutant proteins had an identical retention volume ([Fig. 5C](#f5){ref-type="fig"}). Similarly, thermal denaturation analysis by circular dichroism did not reveal any marked difference in the structural stability of wild-type *Bs*GpsB and the T75D and T75E mutants ([Fig. 6C](#f6){ref-type="fig"}).

Effect of BsGpsB on the glycosyltransferase and transpeptidase activity of BsPBP1 *in vitro* {#s019}
--------------------------------------------------------------------------------------------

To explore the functional role of GpsB and the relationship to its structure, the effect of *Bs*GpsB on the GTase and TPase activities of *Bs*PBP1 was investigated. *Bs*PBP1 was used as both the TGase and TPase activities of this enzyme have successfully been recapitulated *in vitro*,^[@B46]^ which is not yet the case for the listeria PBPs. Both wild-type and phosphomimetic T75D/T75E mutants of *Bs*GpsB were used in these experiments in case any modulation of PBP1 activity by GpsB requires prior phosphorylation of GpsB. The GTase activity of *Bs*PBP1 was monitored using a fluorescence assay, in which the polymerization of fluorescently labeled lipid II followed by digestion of the resulting glycan chains by a muramidase results in a reduction of fluorescence intensity with time, correlated with the rate of the reaction. The addition of a twenty five-fold excess of either wild-type or the phosphomimetic T75D/T75E mutants of *Bs*GpsB had no apparent effect on the rate of the GTase reaction catalyzed by *Bs*PBP1 ([Fig. 8A](#f8){ref-type="fig"}).

![GpsB does not affect the enzyme activities of PBP1 *in vitro*. **(A)** The GTase activity of *Bs*PBP1 in the presence (*blue line*) and absence of wild-type *Bs*GpsB (*red line*), *Bs*GpsB~T75D~ (green line), and *Bs*GpsB~T75E~ (*magenta line*) was measured using fluorescently labeled lipid II as described previously.^[@B40]^ In the absence of *Bs*PBP1 (*black line*), no lipid II consumption is observed. Each measurement is shown as the mean ± SD (*n* = 3). **(B)** HPLC chromatograms from *in vitro* PG synthesis assays. *Bs*PBP1 in the presence and absence of *Bs*GpsB was incubated with radiolabeled amidated lipid II-*m*-DAP. The resultant PG was digested, boiled, and reduced before the resulting muropeptides were separated by HPLC. Peak 1---disaccharide pentapeptide(NH~2~) monophosphate resulting from unused substrate and glycan chain ends; peak 2---disaccharide tetrapeptide(NH~2~) derived from GTase and carboxypeptidase activity; peak 3---disaccharide pentapeptide (nonamidated) from the GTase activity on contaminating nonamidated substrate; peak 4---disaccharide pentapeptide(NH~2~) resulting from the GTase activity; peak 5---bis-disaccharide tetrapeptide(2NH~2~) resulting from GTase, TPase, and carboxypeptidase activities; peak 6---bis-disaccharide tetrapentapeptide(2NH~2~) resulting from GTase and TPase activities. HPLC, high-pressure liquid chromatography.](fig-8){#f8}

The effect of *Bs*GpsB on *Bs*PBP1 was explored further using a HPLC-based *in vitro* PG synthesis assay^[@B41]^ to monitor the composition of peptidoglycan synthesized by *Bs*PBP1 in the presence and absence of *Bs*GpsB. Consistent with others\' previous observations,^[@B46]^ *Bs*PBP1 was active as a TPase when assayed with a native lipid II substrate that had been amidated at the ɛ-carboxylate of *meso*-diaminopimelic acid (lipid II-*m*-DAP). In this endpoint assay, PBP1 produced peptidoglycan with approximately 30% of the peptides present in cross-links, irrespective of the absence or the presence of a twenty five-fold molar excess of either wild-type or the phosphomimetic T75D/T75E mutants of *Bs*GpsB ([Fig. 8B](#f8){ref-type="fig"}). As observed with other PBPs,^[@B39]^ *Bs*PBP1 also exhibited a weak DD-carboxypeptidase activity that was unaffected by the presence of any *Bs*GpsB protein tested. Since *Bs*GpsB interacts with *Bs*PBP1 with a *K*~d~ of 0.7 μM,^[@B11]^ at the protein concentrations used in both assays *Bs*PBP1 should be bound to *Bs*GpsB, suggesting that the interaction has no discernible effect on either the GTase or the TPase activities of *Bs*PBP1 *in vitro.*

Discussion {#s020}
==========

The quaternary structure and the connectivity between domains in GpsB are an intriguing geometric puzzle; GpsB is a hexamer, while the isolated N- and C-terminal domains are dimeric and trimeric, respectively. The arrangement of the domains from the SAXS analysis resembles a logical tripod arrangement, but with a more asymmetric shape than perhaps predicted *a priori*. The asymmetry may be driven, at least in part, by the interactions between C-GpsB trimers; the SAXS envelope suggests a "staggered" alignment of the two C-GpsB trimers, in which one of the trimers is closer to the center of mass of the GpsB hexamer than the other ([Fig. 3](#f3){ref-type="fig"}). A similar staggered alignment is observed in the crystal packing of C-*Bs*GpsB. In this case, each trimeric C-*Bs*GpsB coiled-coil packs in a parallel manner against an adjacent trimer, but offset such that the N-terminal end of one coiled-coil packs against the C-terminal end of the other ([Fig. 4B](#f4){ref-type="fig"}). This arrangement involves hydrophobic interactions between the highly conserved amino acids F78, L81, and F92 in *Bs*GpsB, equivalent to F91, L94, and F105 in *Lm*GpsB. From the SEC analysis, F105 is clearly more important for the stability of the hexamer than F91 ([Fig. 5A](#f5){ref-type="fig"}) and this is fully consistent with the complementation assay, in which mutation of F105, as well as L94, has a larger impact than mutation of F91. The milder effect of the F91A mutation may be attributed to the F105A mutation having a greater impact on the concentration of GpsB hexamers *in vivo*. Overall, these observations support the conclusion that the interactions between C-GpsB domains in the GpsB hexamer are similar to those observed in the C-*Bs*GpsB crystal lattice, which is not predicted to be stable on analysis of the crystal packing with the PDB-PISA web server. However, weak interactions between isolated C-GpsB domains will be stabilized within GpsB by the covalently attached dimeric N-GpsB domains that will bridge two trimers in a hexamer. Such an effect could explain why the full-length GpsB protein has a higher T~m~ than the combined CD thermal melts of the isolated domains ([Fig. 6A](#f6){ref-type="fig"}). The stabilizing effect is illustrated schematically in [Fig. 4A](#f4){ref-type="fig"}, in which cyan is used to denote the N-*Lm*GpsB dimer that forms a bridge between two C-*Lm*GpsB trimers within the *Lm*GpsB hexamer. Previous mutagenesis results have demonstrated that the C-terminal domain is essential for formation of GpsB hexamers and that mutations in residues critical for C-GpsB trimer formation render GpsB inactive.^[@B11]^ It would therefore appear from the loss of GpsB function in strains harboring *gpsB* alleles that affect GpsB hexamer formation that the correct assembly of GpsB is absolutely critical for its function *in vivo*.

With the arrangement of domains in the SAXS envelope, the distances between covalently linked domains are not equivalent. This asymmetric arrangement requires the linker between domains to adopt different conformations, and indeed secondary structure prediction analyses predict that the linker is disordered. The flexibility and bendability of the linker can be further reconciled with the high frequency of the disorder promoting residues^[@B47]^ proline, lysine, methionine serine, and threonine in this region; the 23 amino acid *L. monocytogenes* GpsB linker has twelve such residues, which are also abundant in the linkers of orthologous GpsB proteins.^[@B11]^

The position of F91 and L94 close to or at the interface between subunits is particularly interesting in view of the recent identification that, in *B. subtilis*, the nearby T75 (equivalent to T88 in *L. monocytogenes*) is phosphorylated by the kinase PrkC^[@B19]^ and that phosphomimetic mutations at this position produce a *gpsB* null-like phenotype both in *B. subtilis* and in *L. monocytogenes*. Similarly, phosphoablative mutations have no demonstrable effect in either species. The straddling of T88 by F91 and L94 suggests that the interaction between GpsB and PrkC will overlap with the interface between C-GpsB subunits, and hence, the interaction with PrkC could adjust the arrangement of subunits in the hexamer. The interaction with PrkC could therefore, in turn, influence the interaction with PBP1 by altering the GpsB quaternary structure and the arrangement of PBP1 binding sites. However, the phosphorylation of GpsB, mediated by PrkC, is not in itself sufficient to affect the interaction with PBP1 as both wild-type and phosphomimetic variants of GpsB behaved identically when combined with *Bs*PBP1 in activity assays ([Fig. 8](#f8){ref-type="fig"}). We have shown here and elsewhere^[@B11]^ that correct hexamer formation is essential for GpsB function in *L. monocytogenes*, which invites the suggestion that the phosphomimetic mutation instead affects GpsB function by altering its quaternary structure. However, a major effect on GpsB quaternary structure was not evident here as the two phosphomimetic mutants of *Bs*GpsB, T75D and T75E, behaved indistinguishably from wild-type *Bs*GpsB on SEC and had an identical thermal stability on circular dichroism analysis. Perhaps the *gpsB* null phenotype of phosphomimetic mutations reflects the introduction of a net negative charge in this region affecting the ability of GpsB to interact with PrkC or another divisome component. A molecular rationale for the *gpsB* null phenotype associated with the phosphomimetic mutation reported earlier^[@B19]^ and herein remains to be determined.

An important functional consequence of a closed tripod-like arrangement, as opposed to a more open "splayed out" arrangement of subunits, is the potential for the GpsB hexamer to interact simultaneously with multiple membrane-embedded PBP1 molecules. In the SAXS model of GpsB, the binding sites for PBP1 (a surface cleft in the N-terminal domain^[@B11]^) are clustered at one end of the elongated hexamer ([Fig. 9](#f9){ref-type="fig"}). Similarly, the residues critical for the association of GpsB with the cell membrane (L24 and R25 in *Lm*GpsB^[@B11]^) are also clustered at the same end of the hexamer ([Fig. 9](#f9){ref-type="fig"}). GpsB, therefore, has the implicit capacity to interact with multiple PBP1 molecules and thus to impact upon the arrangement of PBP1 molecules in the divisome, and this capacity may explain phenotypic and genetic evidence that GpsB regulates cell wall synthesis.^[@B5],[@B11]^ In *E. coli*, the essential cell division protein FtsN, which is unrelated to GpsB, may play a similar role as it stabilizes dimeric or multimeric forms of PBP1B *in vitro.*^[@B48]^

![PBP1 and membrane binding sites in the SAXS model of GpsB. The atomic coordinates of N-GpsB dimers and C-GpsB trimers, represented as molecular surfaces (*green and magenta*, respectively), have been manually positioned in the averaged *ab initio* molecular envelope of the *Lm*GpsB hexamer, shown as a *gray mesh*. Surface exposed residues critical for the interaction of *Lm*GpsB with PBP1^11^ are colored *red* (D33, D37, I40). Residues critical for association of *Lm*GpsB with the cell membrane^[@B11]^ are colored *blue* (L24, R25). The molecular envelope represented here is the average of 15 independently generated *ab initio* dummy atom models.](fig-9){#f9}

At 37°C, the Δ*gpsB* null mutant makes the overexpression of PBP1 lethal in *L. monocytogenes*,^[@B11]^ which suggests that GpsB acts as a negative regulator of at least one of the enzymatic activities of PBP1. A simple regulatory mechanism could entail GpsB promoting the oligomerization of PBP1, a feasible scenario given that the GpsB hexamer has the potential to interact with multiple PBP1 molecules. PBP1B from *E. coli* forms dimers, and dimerization enhances both GTase and TPase activities *in vitro.*^[@B41]^ The activities of *E. coli* PBP1B are stimulated or modulated by interactions with LpoB, FtsN, TolA, and CpoB, and these interactions are essential for the function of this peptidoglycan synthase in the cell.^[@B39],[@B48]^ However, there was no effect of *Bs*GpsB on either the GTase or the TPase activity of PBP1 *in vitro* ([Fig. 8](#f8){ref-type="fig"}), which would argue against a regulatory mechanism. Any modulation of PBP1 activity by GpsB *in vivo* must therefore require other divisome components and/or membrane-bound elements that are not recapitulated in these experiments *in vitro*. In particular, simply by controlling the spatial arrangement of PBP1 molecules in the membrane *in vivo*, GpsB may influence both the arrangement of peptidoglycan strands and the pattern of intrastrand cross-links in the cell wall.

In this regard, the hexameric GpsB, and its flexible nature, could potentiate PBP1 activity or cellular localization by changes to the quaternary structure of GpsB: movements of the GpsB domains relative to one another could translate to large changes in the spatial arrangement of PBP1 binding sites. GpsB might thus act as an allosteric sensor, with its interaction with PBP1 modulated by changes in quaternary structure induced by interactions with other purported binding partners such as PrkC, EzrA, MreC, or DivIVA. These ideas will form the focus of our future experiments.
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